Amro Aglan

844 total citations
35 papers, 143 citations indexed

About

Amro Aglan is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Amro Aglan has authored 35 papers receiving a total of 143 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 8 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Amro Aglan's work include Cardiac Valve Diseases and Treatments (8 papers), Cardiac Arrhythmias and Treatments (8 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Amro Aglan is often cited by papers focused on Cardiac Valve Diseases and Treatments (8 papers), Cardiac Arrhythmias and Treatments (8 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Amro Aglan collaborates with scholars based in United States, Egypt and Ireland. Amro Aglan's co-authors include Ahmed Elmaraezy, Abdelrahman Ibrahim Abushouk, Abdullah S. Eldaly, Petros Koutrakis, Brent A. Coull, Mary B. Rice, Susan Dent, Farouk Mookadam, Ethan J. Rowin and Martin S. Maron and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Amro Aglan

22 papers receiving 141 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amro Aglan United States 6 53 35 33 22 18 35 143
Changbiao Chu China 10 51 1.0× 10 0.3× 45 1.4× 8 0.4× 21 1.2× 18 212
Liuxin Wang China 10 84 1.6× 23 0.7× 69 2.1× 21 1.0× 20 1.1× 15 277
René Sosata Bun France 5 40 0.8× 7 0.2× 16 0.5× 8 0.4× 11 0.6× 11 130
John Woodside United Kingdom 6 61 1.2× 43 1.2× 27 0.8× 10 0.5× 9 0.5× 8 178
Mariaconsiglia Calabrese Italy 5 25 0.5× 59 1.7× 21 0.6× 10 0.5× 13 0.7× 12 200
Kārlis Trušinskis Latvia 5 16 0.3× 55 1.6× 65 2.0× 12 0.5× 13 0.7× 24 236
Odile Delaroche France 6 19 0.4× 10 0.3× 12 0.4× 11 0.5× 15 0.8× 20 110
Qiao Jin China 7 58 1.1× 22 0.6× 91 2.8× 10 0.5× 13 0.7× 10 229
M. Forsman Norway 6 24 0.5× 29 0.8× 29 0.9× 8 0.4× 12 0.7× 8 168
Rubén Álvarez Spain 5 44 0.8× 70 2.0× 24 0.7× 13 0.6× 7 0.4× 13 154

Countries citing papers authored by Amro Aglan

Since Specialization
Citations

This map shows the geographic impact of Amro Aglan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amro Aglan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amro Aglan more than expected).

Fields of papers citing papers by Amro Aglan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amro Aglan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amro Aglan. The network helps show where Amro Aglan may publish in the future.

Co-authorship network of co-authors of Amro Aglan

This figure shows the co-authorship network connecting the top 25 collaborators of Amro Aglan. A scholar is included among the top collaborators of Amro Aglan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amro Aglan. Amro Aglan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aglan, Amro, Mahmoud Ahmed, Khalid Mohamed, et al.. (2025). Impact of Timing of Atrial Fibrillation Ablation on AF Recurrence and Clinical Outcomes in Patients With HFpEF and HFrEF. Journal of Cardiovascular Electrophysiology. 37(1). 26–35.
2.
Aglan, Amro, et al.. (2025). Cardiovascular outcomes of glucagon-like peptide-1 agonist in patients with obesity and hypertrophic cardiomyopathy. International Journal of Cardiology. 426. 133082–133082.
3.
Aglan, Amro, et al.. (2024). Association Between Clinical Trial Participation Status and Outcomes With Mitral Transcatheter Edge-to-Edge Repair. JACC: Cardiovascular Interventions. 17(4). 520–530. 2 indexed citations
4.
Chaaban, Nourhan, et al.. (2024). Disparities in the implantation of secondary prevention implantable cardioverter defibrillator in the United States. Pacing and Clinical Electrophysiology. 47(9). 1241–1251.
5.
6.
Aglan, Amro, Barry J. Maron, Anand Prasad, et al.. (2024). Percutaneous left atrial appendage closure for stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation. Heart Rhythm. 21(9). 1677–1683. 3 indexed citations
7.
Aglan, Amro, et al.. (2024). Cardioprotective Potential of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Cancer Treated With Anthracyclines: An Observational Study. The American Journal of Cardiology. 222. 175–182. 8 indexed citations
8.
Warraich, Haider J., Amro Aglan, Sumanth Khadke, et al.. (2024). Association of Palliative Care Consultation in Patients With Heart Failure With Preserved Ejection Fraction With Symptom Burden and Health Care Use. SHILAP Revista de lepidopterología. 4(1). 101431–101431.
9.
Aglan, Amro, Hend Mansoor, Ahmed Almomani, et al.. (2024). Direct Oral Anticoagulants for Rheumatic Heart Disease-Associated Atrial Fibrillation Post-Bioprosthetic Mitral Valve Replacement. JACC. Clinical electrophysiology. 10(12). 2701–2710.
10.
Aglan, Amro, Abdullah S. Eldaly, Allen S. Anderson, et al.. (2024). Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Mortality in Hypertrophic Cardiomyopathy. JACC Advances. 3(3). 100843–100843. 9 indexed citations
11.
Aglan, Amro, et al.. (2023). DEVICE-RELATED THROMBUS AFTER LEFT ATRIAL APPENDAGE CLOSURE COMPLICATED BY ACUTE LIMB ISCHEMIA. Journal of the American College of Cardiology. 81(8). 3978–3978.
12.
Aglan, Amro, et al.. (2023). Transcatheter Aortic Valve Replacement: Variations in Use, Charges, and Geography in the United States. The American Journal of Cardiology. 205. 363–368.
13.
Aglan, Amro, et al.. (2023). Sex differences in myocarditis hospitalizations: Rates, outcomes, and hospital characteristics in the National Readmission Database. Current Problems in Cardiology. 49(2). 102233–102233. 1 indexed citations
14.
Aglan, Amro, et al.. (2023). Variations in Atrial Fibrillation Ablation Use and Charges in a Modern Cohort of Medicare Beneficiaries. The American Journal of Cardiology. 202. 24–29. 2 indexed citations
15.
16.
Aglan, Amro, et al.. (2022). Impact of chronic kidney disease on in-hospital mortality and clinical outcomes of catheter ablation of ventricular tachycardia: Insights from the national readmission database. Journal of Interventional Cardiac Electrophysiology. 66(2). 323–331. 2 indexed citations
17.
18.
Dawood, Ayman Shehata, et al.. (2019). Outcome of laparosopic repair of cesarean scar defect. Fertility and Sterility. 112(3). e413–e413. 1 indexed citations
19.
Aglan, Amro, et al.. (2019). Outcome of hysteroscopic repair of symptomatic cesarean scar defect. Fertility and Sterility. 112(3). e415–e416.
20.
Abushouk, Abdelrahman Ibrahim, et al.. (2017). Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials. BMC Neurology. 17(1). 66–66. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Changbiao Chu Breakdown of academic impact, for papers by Liuxin Wang Breakdown of academic impact, for papers by René Sosata Bun Breakdown of academic impact, for papers by John Woodside Breakdown of academic impact, for papers by Mariaconsiglia Calabrese Breakdown of academic impact, for papers by Kārlis Trušinskis Breakdown of academic impact, for papers by Odile Delaroche Breakdown of academic impact, for papers by Qiao Jin Breakdown of academic impact, for papers by M. Forsman Breakdown of academic impact, for papers by Rubén Álvarez
Rankless by CCL
2026